Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

104 filings reported holding NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 41,346,108 shares of 77,143,980 outstanding shares and own 53.6% of the company stock.
Largest 10 shareholders include The Column Group LLC (5,383,333 shares), TRV GP III, LLC (4,508,333 shares), Redmile Group, LLC (3,314,117 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,093,705 shares), BAKER BROS. ADVISORS LP (2,454,082 shares), EcoR1 Capital, LLC (2,019,019 shares), BlackRock Inc. (1,816,689 shares), STATE STREET CORP (1,377,862 shares), WELLINGTON MANAGEMENT GROUP LLP (1,360,426 shares), and Bain Capital Life Sciences Investors, LLC (1,284,314 shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.